Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-02-28FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for omeprazole from Apotex Corp, supporting a new generic entry for the product.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Effect of Propolis on Patients Infected With H. Pylori [Phase 4]
Phase 4 clinical trial examining the effect of propolis on patients infected with Helicobacter pylori.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study [Phase 4]
A Phase 4 randomized multicenter trial evaluating vonoprazan fumarate with amoxicillin for first-line Helicobacter pylori eradication.
-
FDA approval · 2022-01-31FDA Approved: CLARITHROMYCIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic clarithromycin under Original Application ANDA210459. This expands access to clarithromycin as…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy [Phase 4]
Phase 4 clinical trial comparing 14-day PCAB-based high-dose dual therapy and 14-day PCAB-based triple therapy against 14-day PPI-based reve…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication [Phase 4]
Phase 4 trial evaluating effectiveness of a minocycline-containing bismuth quadruple therapy for Helicobacter pylori eradication.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management [Phase 4]
Phase 4 clinical trial update exploring nitazoxanide and lansoprazole-based regimens for Helicobacter pylori management.
-
FDA approval · 2021-12-15FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination therapy Bismuth subcitrate potassium, metronidazole and tetracycline hydrochlori…
-
FDA approval · 2021-12-15FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for metronidazole from Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin [Phase 4]
Phase 4 clinical trial evaluating rescue treatment for Helicobacter pylori infection in patients allergic to penicillin.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin [Phase 4]
Phase 4 trial update on first-line Helicobacter pylori treatment containing tetracycline for patients allergic to penicillin.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin [Phase 4]
Phase 4 clinical trial update on first-line treatment for Helicobacter pylori infection in patients allergic to penicillin.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin [Phase 4]
Phase 4 clinical trial update evaluating a tetracycline-containing rescue regimen for Helicobacter pylori infection in patients with penicil…
-
FDA approval · 2021-11-12FDA Approved: LANSOPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals' lansoprazole, a generic proton pump inhibitor, under ANDA 203083.
-
FDA approval · 2021-11-09FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application for lansoprazole (generic). This action approves a generic Lansoprazole produ…
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients [Phase 3]
A Phase 3 trial evaluating triple therapy with CJ-12420 in Helicobacter pylori–positive patients has completed.
-
FDA approval · 2021-10-15FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
The FDA approved a supplemental application for lansoprazole by Dr. Reddy's Laboratories Ltd. This approval updates the current marketing au…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy [Phase 4]
Phase 4 clinical trial evaluating whether probiotics affect the fecal resistome during Helicobacter pylori eradication therapy.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Helicobacter Pylori Eradication and Follow-up [Phase 4]
Phase 4 clinical trial updating on Helicobacter pylori eradication and follow-up; recruiting.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment [Phase 4]
Phase 4 trial update evaluating high-dose dual therapy with metronidazole for Helicobacter pylori rescue treatment has completed recruitment…
-
FDA approval · 2021-09-14FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for rabeprazole sodium (generic) from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients [Phase 4]
Phase 4 clinical trial update on an antibiotic combination for eradicating Helicobacter pylori in penicillin-allergic patients.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Concomitant Versus Hybrid Regimen for H. Pylori Eradication [Phase 4]
Phase 4 trial comparing concomitant versus hybrid regimens for Helicobacter pylori eradication has completed.
-
FDA approval · 2021-08-30FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic rabeprazole sodium product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Tetracycline Versus Doxycycline for HP Rescue Therapy [Phase 4]
Clinical trial update comparing tetracycline versus doxycycline for Helicobacter pylori rescue therapy in a Phase 4 study.